Skip to main content
OXFORD BIODYNAMICS PLC logo

OXFORD BIODYNAMICS PLC — Investor Relations & Filings

Ticker · OBD ISIN · GB00BD5H8572 LEI · 2138005Y1TK258O5U928 IL Professional, scientific and technical activities
Open in API
Filings indexed 416 across all filing types
Latest filing 2018-08-29 Major Shareholding Noti…
Country GB United Kingdom
Listing IL OBD

About OXFORD BIODYNAMICS PLC

https://www.oxfordbiodynamics.com/

Oxford BioDynamics PLC is a global biotechnology company advancing personalized healthcare by developing and commercializing precision medicine tests. The company's proprietary EpiSwitch® platform utilizes 3D genomics and epigenetic biomarkers to create diagnostic solutions for life-changing diseases, with a focus on oncology. Its portfolio of clinical tests includes the EpiSwitch® PSE, a blood test that assesses the likelihood of prostate cancer with high accuracy to help reduce unnecessary biopsies, and the EpiSwitch® CiRT, a test designed to predict a patient's therapeutic response to Immune Checkpoint Inhibitor cancer therapies. The platform enables the translation of 3D genome regulation into clinical applications for precision medicine at scale.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly labeled with 'RNS Number : 1848Z' and contains the standard format for 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which falls under regulatory disclosure requirements in the UK (FCA). The presence of the RNS header and the specific content (notification of major holdings) strongly indicates a regulatory filing. Since 'Major Shareholding Notification' (MRQ) is a specific category, and this document is a standard regulatory notification form, it fits best under the specific category for major shareholding changes. However, the document is clearly a direct regulatory submission identified by the RNS system, which is a type of regulatory announcement. Given the options, 'Major Shareholding Notification' (MRQ) is the most precise fit for a TR-1 form detailing changes in voting rights percentage (8.52%).
2018-08-29 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is clearly identified by the header 'RNS Number : 1851Z' and contains the standard format for a 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which falls under regulatory disclosure requirements concerning major shareholdings. The filing explicitly details the shareholder (Philippa Hoyer Millar), the date the threshold was crossed, and the resulting percentage of voting rights (4.85%). This directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is an RNS filing, MRQ is the more specific category for this content type.
2018-08-29 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly labeled with 'RNS Number : 1840Z' and contains the standard format for 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which falls under regulatory disclosure requirements. The presence of 'RNS' branding and the nature of the filing (major holding notification) strongly indicate this is a regulatory announcement. While it relates to shareholding, it is not a general share issue (SHA) or a director's dealing (DIRS), but rather a mandatory disclosure to the FCA/Exchange. The most appropriate category for general regulatory announcements that fit specific disclosure forms like this, especially when they are not the core financial reports (10-K, IR), is RNS (Regulatory Filings) or potentially MRQ (Major Shareholding Notification). Given the specific nature of reporting a change in major holding percentage (6.67%), MRQ is highly specific. However, TR-1 forms are often categorized broadly under RNS if MRQ is reserved for specific threshold breaches or periodic updates. Since 'Major Shareholding Notification' (MRQ) is an explicit category defined for 'Notification of changes in significant share ownership levels (crossing thresholds)', this document fits MRQ perfectly, as it details the crossing/change of a threshold (from 7.03% to 6.67%).
2018-08-29 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is clearly identified by the header 'RNS Number : 1839Z' and contains the standard format for a 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership thresholds, which falls under regulatory disclosure requirements. Specifically, it details the acquisition/disposal of voting rights by GL Healthcare Investment L.P., crossing the 5% threshold. This type of mandatory disclosure to a regulator (FCA mentioned) regarding share ownership changes aligns best with the 'Major Shareholding Notification' category (MRQ). Although it is distributed via RNS, the core content is a specific regulatory filing about shareholding changes, making MRQ the most precise classification over the general RNS fallback.
2018-08-29 English
Chinese Investment Group Takes Stake in OBD
Share Issue/Capital Change Classification · 99% confidence The document begins with 'RNS Number : 4939Y' and is dated August 22, 2018. It details a strategic partnership and a subscription for new shares, raising capital (£9.75 million) from GL Capital Group. This is a corporate announcement regarding a significant investment and strategic business development, which is typically disseminated via regulatory news services. Since it announces a specific corporate action (investment/share subscription) and is formatted as an RNS release, it fits best under the general Regulatory Filings category (RNS) as it is not a specific financial report (10-K, IR, ER) or a dedicated capital change announcement (SHA/CAP), although it involves capital. Given the structure and the explicit 'RNS Number' header, RNS is the most appropriate classification for this type of market-sensitive news release.
2018-08-22 English
Grant of Canadian patent for EpiSwitch platform
Regulatory Filings Classification · 100% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory news service announcement from the London Stock Exchange. The content announces the grant of a Canadian patent for the company's proprietary technology. This is a specific corporate event announcement that does not fit the definitions for financial reports (10-K, IR, ER), management changes (MANG), or shareholder votes (DVA). Since it is a formal, non-standard regulatory announcement that doesn't fit a more specific category like Director's Dealing (DIRS) or Capital Change (CAP), the most appropriate classification is the general Regulatory Filings category (RNS), which serves as a fallback for miscellaneous regulatory announcements.
2018-07-19 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.